Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Exercise reduces daily fatigue in women with breast cancer receiving chemotherapy.

Exercise reduces daily fatigue in women with breast cancer receiving chemotherapy. Cancer treatment-related fatigue is the most prevalent and distressing symptom of cancer therapy. Interventions to minimize fatigue are needed. The purpose of this study was to examine the relationship between exercise and fatigue over the first three cycles of chemotherapy in women receiving either cyclophosphamide, methotrexate, and fluorouracil (CMF) or doxorubicin and cyclophosphamide (AC) for breast cancer. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Medicine and science in sports and exercise Pubmed

Exercise reduces daily fatigue in women with breast cancer receiving chemotherapy.

Medicine and science in sports and exercise , Volume 33 (5): 6 – Jun 21, 2001

Exercise reduces daily fatigue in women with breast cancer receiving chemotherapy.


Abstract

Cancer treatment-related fatigue is the most prevalent and distressing symptom of cancer therapy. Interventions to minimize fatigue are needed. The purpose of this study was to examine the relationship between exercise and fatigue over the first three cycles of chemotherapy in women receiving either cyclophosphamide, methotrexate, and fluorouracil (CMF) or doxorubicin and cyclophosphamide (AC) for breast cancer.

Loading next page...
 
/lp/pubmed/exercise-reduces-daily-fatigue-in-women-with-breast-cancer-receiving-Hw5yG0LNeW

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0195-9131
DOI
10.1097/00005768-200105000-00006
pmid
11323538

Abstract

Cancer treatment-related fatigue is the most prevalent and distressing symptom of cancer therapy. Interventions to minimize fatigue are needed. The purpose of this study was to examine the relationship between exercise and fatigue over the first three cycles of chemotherapy in women receiving either cyclophosphamide, methotrexate, and fluorouracil (CMF) or doxorubicin and cyclophosphamide (AC) for breast cancer.

Journal

Medicine and science in sports and exercisePubmed

Published: Jun 21, 2001

There are no references for this article.